NewAmsterdam Pharma N.V. (NAMS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NewAmsterdam Pharma N.V.

    NASDAQ: NAMS · Real-Time Price · USD
    28.50
    2.21 (8.41%)
    At close: Sep 26, 2025, 3:59 PM
    29.00
    1.75%
    After-hours: Sep 26, 2025, 07:27 PM EDT

    NewAmsterdam Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 771.74M 340.45M 438.52M 53.09M
    Short-Term Investments
    		 62.45M n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a 718.35K
    Other Long-Term Assets
    		 n/a 35K 146K -353
    Receivables
    		 21.3M 1.88M 2.07M 4.86M
    Inventory
    		 n/a n/a 21.5K -735
    Other Current Assets
    		 n/a n/a n/a 5.78M
    Total Current Assets
    		 863.41M 346.79M 448.13M 58.87M
    Property-Plant & Equipment
    		 673K 101K 144K 190K
    Goodwill & Intangibles
    		 534K 170K 83.16M n/a
    Total Long-Term Assets
    		 1.21M 306K 83.45M 908K
    Total Assets
    		 864.62M 347.1M 531.58M 59.78M
    Account Payables
    		 4.74M 16.92M 11.85M 7.04M
    Deferred Revenue
    		 6.01M 8.94M 13.01M 3.61M
    Short-Term Debt
    		 246K n/a n/a n/a
    Other Current Liabilities
    		 91.03M 15.96M 5.55M 519.69K
    Total Current Liabilities
    		 106.92M 49.9M 35.46M 9.88M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a 7.79M 6.75M -14.68K
    Total Long-Term Liabilities
    		 202K 8.81M 11.6M 111K
    Total Liabilities
    		 107.12M 58.7M 47.06M 9.99M
    Total Debt
    		 448K 60K 118K 164K
    Book Value
    		 757.5M 288.39M 484.52M 49.79M
    Book Value Per Share
    		 8.03 3.51 25.55 2.80
    Common Stock
    		 13.44M 10.17M 599.19M 83.88M
    Retained Earnings
    		 n/a -316.97M -119.36M -34.68M
    Comprehensive Income
    		 4.47M 4.42M 4.69M 591K
    Shareholders Equity
    		 757.5M 288.39M 484.52M 49.79M
    Total Investments
    		 62.45M -31.08M n/a 718.35K

    Add to Watchlist